| scholarly article | Q13442814 |
| P356 | DOI | 10.1200/JCO.20.2.494 |
| P698 | PubMed publication ID | 11786579 |
| P50 | author | Diego Serraino | Q40562067 |
| Stefano Parodi | Q47307139 | ||
| Marina Vercelli | Q55135324 | ||
| Vittorina Zagonel | Q56925944 | ||
| Silvio Monfardini | Q56942857 | ||
| P2093 | author name string | Lazzaro Repetto | |
| Matti S Aapro | |||
| Lucia Fratino | |||
| Riccardo A Audisio | |||
| Walter Gianni | |||
| Antonella Venturino | |||
| Denise Dal Lago | |||
| Flora Gioia | |||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Italy | Q38 |
| P304 | page(s) | 494-502 | |
| P577 | publication date | 2002-01-01 | |
| P1433 | published in | Journal of Clinical Oncology | Q400292 |
| P1476 | title | Comprehensive geriatric assessment adds information to Eastern Cooperative Oncology Group performance status in elderly cancer patients: an Italian Group for Geriatric Oncology Study | |
| P478 | volume | 20 |
| Q57135350 | Q57135350 |
| Q35244361 | A model for the functional assessment of elderly with myeloid neoplasms |
| Q35527102 | A multicentre phase II randomised trial of weekly docetaxel/gemcitabine followed by erlotinib on progression, vs the reverse sequence, in elderly patients with advanced non small-cell lung cancer selected with a comprehensive geriatric assessment (t |
| Q92624750 | A new tool for comprehensive geriatric assessment in elderly patients with acute myeloid leukemia: a pilot study from China |
| Q36936263 | A novel approach to improve health status measurement in observational claims-based studies of cancer treatment and outcomes |
| Q36671326 | A phase II study of weekly cisplatin, 6S-stereoisomer leucovorin and fluorouracil as first-line chemotherapy for elderly patients with advanced gastric cancer |
| Q54683671 | A retrospective study of the impact of age on patterns of care for elderly patients with metastatic breast cancer. |
| Q92710266 | A simplified frailty scale predicts outcomes in transplant-ineligible patients with newly diagnosed multiple myeloma treated in the FIRST (MM-020) trial |
| Q54364945 | A wide difference in cancer survival between middle aged and elderly patients in Europe. |
| Q47631701 | Activities of daily living and quality of life during treatment with neoadjuvant chemoradiotherapy and after surgery in patients with esophageal cancer |
| Q27025860 | Adjuvant Systemic Therapy in Older Breast Cancer Women: Can We Optimize the Level of Care? |
| Q37884483 | Adjuvant chemotherapy for breast cancer in older women: emerging evidence to aid in decision making |
| Q38787215 | Adjuvant chemotherapy in elderly patients with breast cancer: key challenges |
| Q55237828 | Advanced Non-Small-Cell Lung Cancer in Elderly Patients: Patient Features and Therapeutic Management. |
| Q37580903 | Advances in the pharmacological treatment of gastro-oesophageal cancer |
| Q34032508 | Age disparity in the dissemination of imatinib for treating chronic myeloid leukemia |
| Q37269229 | Age is a prognostic factor affecting survival in lung cancer patients |
| Q42513324 | Age, severe comorbidity and functional impairment independently contribute to poor survival in cancer patients |
| Q39013605 | Aging: Treating the Older Patient |
| Q47586189 | Allogeneic transplant for peripheral T-cell lymphoma: a sparkle of hope and many questions |
| Q24792436 | An electronic application for rapidly calculating Charlson comorbidity score |
| Q36800253 | Anemia and Functional Disability in Older Adults With Cancer. |
| Q37808557 | Anemia, fatigue and aging |
| Q90029028 | Approach to the treatment of the older, unfit patient with myeloma from diagnosis to relapse: perspectives of a US hematologist and a geriatric hematologist |
| Q37893287 | Are we treating enough elderly patients with early stage non-small cell lung cancer? |
| Q37365649 | Attribution of functional limitation to cancer decreases in the year following breast cancer diagnosis in older patients |
| Q37577915 | Better treatment for breast cancer in older patients |
| Q35894352 | Biological, clinical, and psychosocial correlates at the interface of cancer and aging research |
| Q39303318 | Breast cancer in the elderly: which lessons have we learned? |
| Q45022438 | Breast carcinoma in elderly women: features of disease presentation, choice of local and systemic treatments compared with younger postmenopasual patients. |
| Q39850520 | Can first cycle CBCs predict older patients at very low risk of neutropenia during further chemotherapy? |
| Q28069620 | Can we predict toxicity and efficacy in older patients with cancer? Older patients with colorectal cancer as an example |
| Q58914739 | Cancer Surgery in the Elderly |
| Q37983260 | Cancer and Age: General Considerations |
| Q37632544 | Cancer in older people: a tale of two disciplines. |
| Q34670408 | Cancer physicians’ attitude towards treatment of the elderly cancer patient in a developed Asian country |
| Q84738989 | Carboplatin and weekly paclitaxel doublet chemotherapy compared with monotherapy in elderly patients with advanced non-small-cell lung cancer: IFCT-0501 randomised, phase 3 trial |
| Q35549205 | Care of breast cancer in the elderly woman?what does comprehensive geriatric assessment (CGA) help? |
| Q49680114 | Chemotherapy Toxicity Risk Score for Treatment Decisions in Older Adults with Advanced Solid Tumors |
| Q46411737 | Chemotherapy for prostate cancer |
| Q26771424 | Chemotherapy in Elderly Patients with Gastric Cancer |
| Q37677722 | Choices in surgery for older women with breast cancer |
| Q43137288 | Clinical relevance of extra-hematologic comorbidity in the management of patients with myelodysplastic syndrome |
| Q45347505 | Clinical usefulness of the Frontal Assessment Battery at bedside (FAB) for elderly cancer patients |
| Q36142395 | Clinicopathological features and treatment sensitivity of elderly Chinese breast cancer patients |
| Q42606229 | Comment on 'capecitabine and bevacizumab as first-line treatment in elderly patients with metastatic colorectal cancer'. |
| Q89046672 | Communication about geriatric assessment domains in advanced cancer settings: "Missed opportunities" |
| Q52663666 | Community Oncologists' Decision-Making for Treatment of Older Patients With Cancer. |
| Q42840518 | Comorbidities in the Aging Breast Cancer Population: Are Current Assessments Leading to Improved Outcomes? |
| Q43902595 | Comorbidity and performance status as independent prognostic factors in patients with head and neck squamous cell carcinoma |
| Q35664302 | Comorbidity as a prognostic variable in multiple myeloma: comparative evaluation of common comorbidity scores and use of a novel MM–comorbidity score |
| Q36736636 | Comparison of conventional prognostic indices in patients older than 60 years with diffuse large B-cell lymphoma treated with R-CHOP in the US Intergroup Study (ECOG 4494, CALGB 9793): consideration of age greater than 70 years in an elderly prognos |
| Q45350326 | Comparison of safety and efficacy of S-1 monotherapy and S-1 plus cisplatin therapy in elderly patients with advanced gastric cancer |
| Q51758137 | Comparison of two frailty screening tools in older women with early breast cancer |
| Q83425168 | Comprehensive Geriatric Assessment and Its Clinical Impact in Oncology |
| Q39773985 | Comprehensive geriatric assessment and comorbidities predict survival in geriatric oncology. |
| Q38630293 | Comprehensive geriatric assessment in 326 older women with early breast cancer |
| Q48800344 | Comprehensive geriatric assessment in Korean elderly cancer patients receiving chemotherapy |
| Q95276658 | Coronavirus: Older Persons With Cancer in Italy in the COVID-19 Pandemic |
| Q36742697 | Critical review of the management of early-stage breast cancer in elderly women |
| Q47611064 | Daily activities: exploring their spectrum and prognostic impact in older, chemotherapy-treated lung cancer patients |
| Q38967020 | Definition of Unfit for Standard Acute Myeloid Leukemia Therapy |
| Q34155010 | Determining chemotherapy tolerance in older patients with cancer |
| Q89459292 | Development and prospective evaluation of CAPLET, a cancer ambulatory patient physical function longitudinal evaluation tool for routine clinical practice |
| Q51542630 | Development and validation of a nutrition screening tool for hospitalized cancer patients |
| Q36789292 | Development of an oncological-multidimensional prognostic index (Onco-MPI) for mortality prediction in older cancer patients |
| Q90204338 | Development, validation and clinical impact of a prediction model for 6-month mortality in older cancer patients: the GRADE |
| Q36405668 | Doublet chemotherapy in the elderly patient with ovarian cancer |
| Q33411167 | Doublets versus single-agent therapy as first-line therapy for elderly patients with advanced non-small cell lung cancer? A systematic review of randomised controlled trials |
| Q37589341 | EORTC Elderly Task Force and Lung Cancer Group and International Society for Geriatric Oncology (SIOG) experts' opinion for the treatment of non-small-cell lung cancer in an elderly population. |
| Q35536822 | Effect of comorbidity on the treatment and prognosis of elderly patients with non-small cell lung cancer |
| Q33389465 | Effects of azacitidine compared with conventional care regimens in elderly (≥ 75 years) patients with higher-risk myelodysplastic syndromes |
| Q28397465 | Epidemiology and management of common pulmonary diseases in older persons |
| Q42258407 | Epstein-Barr virus present in T cells or B cells shows differential effects on hemophagocytic symptoms associated with outcome in T-cell lymphomas |
| Q58569004 | Eribulin Mesylate as Third or Subsequent Line Chemotherapy for Elderly Patients with Locally Recurrent or Metastatic Breast Cancer: A Multicentric Observational Study of GIOGer (Italian Group of Geriatric Oncology)-ERIBE |
| Q35579715 | Establishing a nursing research agenda in gero-oncology |
| Q46340643 | Evaluation of the cardiovascular health study (CHS) instrument and the Vulnerable Elders Survey-13 (VES-13) in elderly cancer patients. Are we still missing the right screening tool? |
| Q35807965 | Factors that influence treatment decision-making in elderly DLBCL patients: a case vignette study |
| Q45960920 | Feasibility and efficacy of speed-feedback therapy with a bicycle ergometer on cognitive function in elderly cancer patients in Japan. |
| Q36565645 | Feasibility of Computer-Based Self-Administered Cancer-Specific Geriatric Assessment in Older Patients With Gastrointestinal Malignancy |
| Q93106078 | Feasibility of Continuous Geriatric Assessments as a Prognostic Indicator in Elderly People with Gastrointestinal Cancer |
| Q38202913 | First-line treatment of newly diagnosed elderly patients with chronic myeloid leukemia: current and emerging strategies |
| Q38863741 | Frailty and long-term mortality of older breast cancer patients: CALGB 369901 (Alliance). |
| Q47105907 | Frailty and quality of life among older people with and without a cancer diagnosis: Findings from TOPICS-MDS. |
| Q83191829 | From Biology to Clinical Practice: Aging and Hematopoietic Cell Transplantation |
| Q89081117 | Frontline Treatment for Older Patients with Mantle Cell Lymphoma |
| Q89224246 | Functional trajectories before and after a new cancer diagnosis among community-dwelling older adults |
| Q47877600 | Geriatric Assessment Predicts Survival and Competing Mortality in Elderly Patients with Early Colorectal Cancer: Can It Help in Adjuvant Therapy Decision-Making? |
| Q90479213 | Geriatric Assessment in Older Adults with Multiple Myeloma |
| Q35820580 | Geriatric Assessment of Older Adults With Cancer During Unplanned Hospitalizations: An Opportunity in Disguise. |
| Q35428376 | Geriatric assessment in older patients with breast cancer |
| Q36940190 | Geriatric assessment is associated with completion of chemotherapy, toxicity, and survival in older adults with cancer |
| Q48339917 | Geriatric assessment of patients with hematological neoplasms |
| Q36873270 | Geriatric assessment predicts survival for older adults receiving induction chemotherapy for acute myelogenous leukemia |
| Q47568990 | Geriatric assessment with management intervention in older adults with cancer: a randomized pilot study |
| Q60685785 | Geriatric assessment-driven polypharmacy discussions between oncologists, older patients, and their caregivers |
| Q35345579 | Geriatric assessment-identified deficits in older cancer patients with normal performance status |
| Q33598327 | Geriatric considerations in the treatment of advanced prostate cancer |
| Q37082755 | Geriatric oncology research to improve clinical care |
| Q34300407 | Geriatric oncology: The need for a separate subspecialty |
| Q35111415 | Geriatric oncology: a clinical approach to the older patient with cancer. |
| Q33979972 | Geriatric oncology: an overview of progresses and challenges |
| Q40060273 | Hepatocellular carcinoma in elderly: Clinical characteristics, treatments and outcomes compared with younger adults. |
| Q92048522 | Hospitalization and definitive radiotherapy in lung cancer: incidence, risk factors and survival impact |
| Q39187610 | How to manage mantle cell lymphoma. |
| Q64124599 | Identification of risk factors for toxicity in patients with hormone receptor-positive advanced breast cancer treated with bevacizumab plus letrozole: a CALGB 40503 (alliance) correlative study |
| Q81297573 | Impact of age on outcome in patients with advanced ovarian cancer treated within a prospectively randomized phase III study of the Arbeitsgemeinschaft Gynaekologische Onkologie Ovarian Cancer Study Group (AGO-OVAR) |
| Q36977050 | Impact of age on the efficacy of newer adjuvant therapies in patients with stage II/III colon cancer: findings from the ACCENT database |
| Q44979284 | Impact of liposomal doxorubicin-based adjuvant chemotherapy on autonomy in women over 70 with hormone-receptor-negative breast carcinoma: A French Geriatric Oncology Group (GERICO) phase II multicentre trial |
| Q34879258 | Implementing a Geriatric Assessment in Cooperative Group Clinical Cancer Trials: CALGB 360401 |
| Q38963512 | Improving outcomes for older women with gynaecological malignancies |
| Q40202348 | Improving the quality of life of geriatric cancer patients with a structured multidisciplinary intervention: a randomized controlled trial |
| Q30250334 | Improving the quality of survivorship for older adults with cancer |
| Q37855234 | Individualized Decision-Making for Older Men With Prostate Cancer: Balancing Cancer Control With Treatment Consequences Across the Clinical Spectrum |
| Q86506584 | Inherently poor survival of elderly patients with nasopharyngeal carcinoma |
| Q38013985 | Integrating a Cancer-Specific Geriatric Assessment Into Survivorship Care |
| Q36925135 | International Society of Geriatric Oncology consensus on geriatric assessment in older patients with cancer |
| Q36648440 | Irinotecan plus leucovorin-modulated 5-fluorouracil I.V. bolus every other week may be a suitable therapeutic option also for elderly patients with metastatic colorectal carcinoma |
| Q38044120 | Issues in the Curative Therapy of Breast Cancer in Elderly Women |
| Q58038974 | Letter to the editor: “Phase II trial of S-1 monotherapy in elderly or frail patients with metastatic colorectal cancer” |
| Q83425187 | Liquid Tumors in the Elderly |
| Q39001325 | Management of Elderly Patients with Plasma Cell Myeloma |
| Q88149109 | Management of Lung Cancer in the Elderly |
| Q37622931 | Management of anaemia in prostate cancer |
| Q37999119 | Management of elderly patients with breast cancer: updated recommendations of the International Society of Geriatric Oncology (SIOG) and European Society of Breast Cancer Specialists (EUSOMA). |
| Q37572750 | Management of head and neck cancer in elderly patients |
| Q83572613 | Metastatic non-small cell lung cancer: Systemic treatment of patients aged 70 and over |
| Q34902002 | Models of Care in Geriatric Oncology |
| Q36051526 | Modulated chemotherapy according to modified comprehensive geriatric assessment in 100 consecutive elderly patients with diffuse large B-cell lymphoma |
| Q26749492 | Moving beyond Karnofsky and ECOG Performance Status Assessments with New Technologies |
| Q34031129 | Multiple myeloma in the older adult: better prospects, more challenges |
| Q82233960 | Myelodysplastic syndrome in the elderly: comprehensive geriatric assessment and therapeutic recommendations |
| Q37456396 | N-terminal fragment of the type-B natriuretic peptide (NT-proBNP) contributes to a simple new frailty score in patients with newly diagnosed multiple myeloma |
| Q38048281 | New Treatment Approaches for Older Adults with Multiple Myeloma |
| Q43139321 | Non-Hodgkin's lymphoma in the elderly |
| Q37023167 | Older adults and cancer treatment |
| Q38058455 | Optimal Management of Recurrent Prostate Cancer in Older Patients |
| Q37952852 | Optimal Pharmacotherapeutic Strategies for Elderly Patients with Advanced Non-Small Cell Lung Cancer |
| Q27690879 | Optimal management of breast cancer in the elderly patient: current perspectives |
| Q34514273 | Optimal screening for geriatric assessment in older allogeneic hematopoietic cell transplantation candidates |
| Q24796933 | Optimising surgical management of elderly cancer patients. |
| Q38099809 | Optimizing perioperative management of geriatric patients with head and neck cancer. |
| Q36822388 | Oral anticancer drugs in the elderly: an overview |
| Q50647977 | Outcomes in elderly patients treated with a single-agent or combination regimen as first-line chemotherapy for recurrent or metastatic gastric cancer |
| Q50793789 | Ovarian cancer in elderly patients: a difference in treatment based on age? |
| Q35534052 | Palliative chemotherapy for gastroesophageal cancer in old and very old patients: A retrospective cohort study at the National Center for Tumor Diseases, Heidelberg |
| Q37650308 | Palliative treatment of unresectable metastatic colorectal cancer |
| Q39495613 | Patient function, long-term survival, and use of surgery in patients with kidney cancer |
| Q36447635 | Patient-reported physical functioning predicts the success of hematopoietic cell transplantation (BMT CTN 0902) |
| Q37118928 | Pegylated liposomal doxorubicin in elderly patients with metastatic breast cancer. |
| Q35661799 | Performance Status in Elderly Patients With Acute Myeloid Leukemia: Exploring Gene Expression Signatures of Cytokines and Chemokines |
| Q47344748 | Performance status 1 predicts psychological response in female, but not male, ambulatory cancer patients |
| Q49415741 | Perioperative outcome of elderly versus younger patients undergoing major hepatic or pancreatic surgery |
| Q93266510 | Perspectives from the Cancer and Aging Research Group: Caring for the vulnerable older patient with cancer and their caregivers during the COVID-19 crisis in the United States |
| Q36924607 | Phase I/II study of vinorelbine and exisulind as first-line treatment of advanced non-small cell lung cancer in patients at least 70 years old: a wisconsin oncology network study |
| Q39638404 | Physical Functioning in Older Patients With Breast Cancer: A Prospective Cohort Study in the TEAM Trial |
| Q37140471 | Physical performance and subsequent disability and survival in older adults with malignancy: results from the health, aging and body composition study |
| Q88755207 | Practical Assessment and Management of Vulnerabilities in Older Patients Receiving Chemotherapy: ASCO Guideline for Geriatric Oncology |
| Q48053063 | Predicting fatigue in older breast cancer patients receiving radiotherapy. A head-to-head comparison of established assessments |
| Q49637785 | Prediction of long-term survival rates in patients undergoing curative resection for solitary hepatocellular carcinoma |
| Q44913406 | Preoperative cardiopulmonary risk assessment as predictor of early noncancer and overall mortality after radical prostatectomy |
| Q35013560 | Prescribing anti-cancer drugs in elderly cancer patients |
| Q90147889 | Prevalence of Geriatric Syndromes in Elderly Cancer Patients Receiving Chemotherapy |
| Q26852883 | Prognostic factors in elderly patients with breast cancer |
| Q47096671 | Prognostic role of a comprehensive geriatric assessment on the management of elderly patients with advanced non-small cell lung cancer (NSCLC): a pooled analysis of two prospective phase II trials by the GFPC Group |
| Q43529478 | Prognostic significance of geriatric assessment in combination with laboratory parameters in elderly patients with aggressive non-Hodgkin lymphoma |
| Q30235496 | Prophylactic Measures During Induction for Acute Myeloid Leukemia |
| Q30276875 | Refined comorbidity index based on dimensionality of comorbidity for use in studies of health-related quality of life |
| Q43765365 | Results of comprehensive geriatric assessment effect survival in patients with malignant lymphoma |
| Q39038047 | Retrospective study of unplanned hospital admission for metastatic cancer patients visiting the emergency department. |
| Q34612644 | Risk stratification based on both disease status and extra-hematologic comorbidities in patients with myelodysplastic syndrome |
| Q37113563 | Role of chemotherapy and novel biological agents in the treatment of elderly patients with colorectal cancer |
| Q35214123 | Screening older cancer patients for a Comprehensive Geriatric Assessment: A comparison of three instruments |
| Q36851424 | Senior adult oncology |
| Q48534891 | Severe sarcopenia might be associated with a decline of physical independence in older patients undergoing chemotherapeutic treatment |
| Q43427689 | Skin rash during cetuximab treatment in advanced colorectal cancer: is age a clinical predictor? |
| Q45944460 | Skin rash during erlotinib for advanced non-small cell lung cancer: is age a clinical predictor? |
| Q28727427 | Solid-organ transplantation in older adults: current status and future research |
| Q60923165 | Surgical treatment and survival from colorectal cancer in Denmark, England, Norway, and Sweden: a population-based study |
| Q34339987 | The Benefit of Adjuvant Chemotherapy in Elderly Patients with Stage III Colorectal Cancer is Independent of Age and Comorbidity |
| Q51835491 | The Comprehensive Geriatric Assessment in Oncology: Promises, Pitfalls, and Practicalities |
| Q37746937 | The Effect of A Geriatric Assessment on Treatment Decisions for Patients with Lung Cancer |
| Q91713377 | The Multidisciplinary Team (MDT) Approach and Quality of Care |
| Q38842194 | The Prevalence and Prognostic Value of Low Muscle Mass in Cancer Patients: A Review of the Literature |
| Q36876774 | The changing prevalence of comorbidity across the age spectrum |
| Q43902443 | The early discontinuation of palliative chemotherapy in older patients with cancer |
| Q37195803 | The feasibility of inpatient geriatric assessment for older adults receiving induction chemotherapy for acute myelogenous leukemia |
| Q47564186 | The geriatric depression scale in palliative care |
| Q43769467 | The prevalence and correlates of fatigue in older cancer patients. |
| Q33878770 | The treatment of metastatic non-small cell lung cancer in the elderly: an evidence-based approach |
| Q35584387 | The value of a comprehensive geriatric assessment for patient care in acutely hospitalized older patients with cancer |
| Q36180083 | Therapeutic options in older patients with metastatic non-small cell lung cancer |
| Q37992730 | Therapeutic strategies in elderly and very elderly patients |
| Q35086832 | Tolerability and efficacy of docetaxel in older men with metastatic castrate-resistant prostate cancer (mCRPC) in the TAX 327 trial. |
| Q36808836 | Tolerability and outcomes of radiotherapy or chemoradiotherapy for rectal cancer in elderly patients aged 70 years and older. |
| Q46183703 | Translation and Validation of the Activities of Daily Living Scale with Iranian Elderly Cancer Patients Treated in an Oncology Unit |
| Q39716814 | Treatment dilemma in the care of older adults with advanced lung cancer |
| Q64976783 | Treatment of Urothelial Cancer in Elderly Patients: Focus on Immune Checkpoint Inhibitors. |
| Q43932267 | Treatment of advanced gastrointestinal stromal tumors in patients over 75 years old: clinical and pharmacological implications. |
| Q34549328 | Treatment of cancer in the older aged person |
| Q35247997 | Treatment of diffuse large B-cell lymphoma in the elderly: regimens without anthracyclines are common and not futile |
| Q36276360 | Treatment of elderly cancer patients with chemotherapy |
| Q38215192 | Treatment of malignant gliomas in elderly patients: a concise overview of the literature |
| Q37298994 | Treatment of the elderly colorectal cancer patient: SIOG expert recommendations |
| Q35728668 | Treatment options for early breast cancer in elderly women |
| Q36500561 | Treatment options for older woman with early breast cancer |
| Q80340434 | Treatment patterns by decade of life in elderly women (> or =70 years of age) with ovarian cancer |
| Q35236068 | Trends in incidence, treatment and survival of aggressive B-cell lymphoma in the Netherlands 1989-2010 |
| Q26747296 | Understanding cognition in older patients with cancer |
| Q39085255 | Use of geriatric assessment and screening tools of frailty in elderly patients with prostate cancer. Review. |
| Q34360763 | Use of geriatric assessment for older adults in the oncology setting: a systematic review. |
| Q89128636 | Using Geriatric Assessment Strategies to Lead End-of-Life Care Discussions |
| Q90244066 | Utility of a chemotherapy toxicity prediction tool for older patients in a community setting |
| Q50112942 | Validation and Refinement of the Age, Comorbidities, and Albumin Index in Elderly Patients with Diffuse Large B-Cell Lymphoma: An Effective Tool for Comprehensive Geriatric Assessment |
| Q90632735 | Validation of the Comprehensive Geriatric Assessment as a Predictor of Mortality in Elderly Glioblastoma Patients |
| Q50045189 | What Every Oncologist Should Know About Geriatric Assessment for Older Patients With Cancer: Young International Society of Geriatric Oncology Position Paper. |
| Q84302453 | [Comorbidity oriented oncology - an overview] |
| Q88739414 | [Comprehensive geriatric assessment can predict the clinical outcomes of elderly patients with diffuse large B cell lymphoma in China] |
| Q79761154 | [Elderly and opioid world] |
| Q79383676 | [Lung cancer in the elderly: performance status and/or geriatric indices?] |
| Q82366772 | [Management of colorectal cancer of elderly patients] |
| Q81909540 | [The handling of anti-cancer drugs in elderly patients] |
| Q80385854 | [The significance of comorbidity and age in radical prostatectomy] |
| Q57133648 | [Therapy of castration-resistant prostate cancer] |
| Q80467430 | [Treatment of non-small cell lung cancer in elderly patients] |
Search more.